Hopkinson Craig C. Insider Trades

Insider Trading History

Track insider trading activity for Hopkinson Craig C.. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Alkermes plc
Alkermes plc ALKS
EVP R&d, Chief Medical Officer
Holding Value $4.15M 86,389 shares
Last Trade
Jun 01, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$211k 5,000 shares
$42.27
$48.07
Alkermes plc
Alkermes plc ALKS
EVP R&d, Chief Medical Officer
Holding Value $3.72M 77,389 shares
Last Trade
Jun 01, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$375k 9,000 shares
$41.67
$48.07
Alkermes plc
Alkermes plc ALKS
EVP R&d, Chief Medical Officer
Holding Value $306k 6,356 shares
Last Trade
Jun 01, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$211k 5,000 shares
$42.27
$48.07
Alkermes plc
Alkermes plc ALKS
EVP R&d, Chief Medical Officer
Holding Value $3.91M 81,389 shares
Last Trade
May 01, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$301k 9,000 shares
$33.40
$48.07
Alkermes plc
Alkermes plc ALKS
EVP R&d, Chief Medical Officer
Holding Value $4.34M 90,389 shares
Last Trade
May 01, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$167k 5,000 shares
$33.38
$48.07
Alkermes plc
Alkermes plc ALKS
EVP R&d, Chief Medical Officer
Holding Value $546k 11,356 shares
Last Trade
May 01, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$167k 5,000 shares
$33.38
$48.07
Alkermes plc
Alkermes plc ALKS
EVP R&d, Chief Medical Officer
Holding Value $786k 16,356 shares
Last Trade
Apr 01, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$175k 5,000 shares
$35.05
$48.07
Alkermes plc
Alkermes plc ALKS
EVP R&d, Chief Medical Officer
Holding Value $4.54M 94,389 shares
Last Trade
Apr 01, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$175k 5,000 shares
$35.05
$48.07
Alkermes plc
Alkermes plc ALKS
EVP R&d, Chief Medical Officer
Holding Value $4.1M 85,389 shares
Last Trade
Apr 01, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$320k 9,000 shares
$35.51
$48.07
Alkermes plc
Alkermes plc ALKS
EVP R&d, Chief Medical Officer
Holding Value $1.03M 21,356 shares
Last Trade
Mar 02, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$151k 5,000 shares
$30.25
$48.07
Alkermes plc
Alkermes plc ALKS
EVP R&d, Chief Medical Officer
Holding Value $3.99M 83,037 shares
Last Trade
Mar 02, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.68M 121,605 shares
$30.25
$48.07
Alkermes plc
Alkermes plc ALKS
EVP R&d, Chief Medical Officer
Holding Value $4.3M 89,389 shares
Last Trade
Mar 02, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$267k 9,000 shares
$29.72
$48.07
Alkermes plc
Alkermes plc ALKS
EVP R&d, Chief Medical Officer
Holding Value $4.73M 98,389 shares
Last Trade
Mar 02, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$151k 5,000 shares
$30.25
$48.07
Alkermes plc
Alkermes plc ALKS
EVP R&d, Chief Medical Officer
Holding Value $660k 13,732 shares
Last Trade
Feb 26, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$211k 6,866 shares
$30.73
$48.07
Alkermes plc
Alkermes plc ALKS
EVP R&d, Chief Medical Officer
Holding Value $4.49M 93,389 shares
Last Trade
Feb 26, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$93.7k 3,049 shares
$30.73
$48.07
Alkermes plc
Alkermes plc ALKS
EVP R&d, Chief Medical Officer
Holding Value $4.64M 96,438 shares
Last Trade
Feb 26, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$211k 6,866 shares
$30.73
$48.07
Alkermes plc
Alkermes plc ALKS
EVP R&d, Chief Medical Officer
Holding Value $4.31M 89,572 shares
Last Trade
Feb 23, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$110k 3,414 shares
$32.19
$48.07
Alkermes plc
Alkermes plc ALKS
EVP R&d, Chief Medical Officer
Holding Value $4.47M 92,986 shares
Last Trade
Feb 23, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$248k 7,689 shares
$32.19
$48.07
Alkermes plc
Alkermes plc ALKS
EVP R&d, Chief Medical Officer
Holding Value $370k 7,690 shares
Last Trade
Feb 23, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$248k 7,689 shares
$32.19
$48.07
Alkermes plc
Alkermes plc ALKS
EVP R&d, Chief Medical Officer
Holding Value $4.1M 85,297 shares
Last Trade
Feb 19, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$109k 3,407 shares
$32.00
$48.07

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up